Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response
Head and neck squamous cell carcinomas (HNSCC) represent a group of epithelial neoplasms that exhibit considerable heterogeneity in clinical behavior. Here, we examined the stromal and vascular heterogeneity in a panel of patient-derived xenograft (PDX) models of HNSCC and the impact on therapeutic...
Main Authors: | Margaret Folaron, Mihai Merzianu, Umamaheswar Duvvuri, Robert L. Ferris, Mukund Seshadri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/7/951 |
Similar Items
-
Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer
by: Katelyn D. Bothwell, et al.
Published: (2016-01-01) -
Flavonoid-Inspired Vascular Disrupting Agents: Exploring Flavone-8-Acetic Acid and Derivatives in the New Century
by: Silvia Gobbi, et al.
Published: (2021-07-01) -
MAPKAPK2 plays a crucial role in the progression of head and neck squamous cell carcinoma by regulating transcript stability
by: Sourabh Soni, et al.
Published: (2019-04-01) -
Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
by: Julie E. Bauman, et al.
Published: (2020-06-01) -
Impact of Tumour Hypoxia on Evofosfamide Sensitivity in Head and Neck Squamous Cell Carcinoma Patient-Derived Xenograft Models
by: Julia K. Harms, et al.
Published: (2019-07-01)